The Super Patch research library: what the studies actually show
Shop the official Super Patch store → First: does Super Patch work?
How we chose what to include
We include every study we could actually verify — the strong and the weak — and we tell you which is which. We do not cite studies we cannot find, we do not hide who paid for the research, and we flag design limitations (like missing randomization or blinding) in plain English. If new, higher-quality evidence appears, this page changes.
What the technology actually is
Super Patch is a drug-free, non-transdermal adhesive patch. Nothing is absorbed into your body — there are no drugs, stimulants, CBD or chemicals. Instead, the patch has a textured, ridged pattern on its surface, and the company’s theory (they call it Vibrotactile Trigger Technology, or VTT) is that this pattern gently stimulates the touch receptors in your skin, sending a signal the nervous system responds to — a “conversation” with the body rather than a chemical “override.”
One honest caveat up front: independent observers point out the patch is passive — it does not actively buzz or vibrate. So “vibrotactile” here means the surface texture stimulating your skin, not a powered vibrating device. Keep that distinction in mind as you read the studies below.
The studies on Super Patch, reviewed one by one
Here is the real research on the product itself, each with what it measured and our candid read of how much weight it can carry. The colored tag is our quick verdict on evidence strength.
RESTORE Study — published RCT (2025)
Published RCTWhat it measured: Whether the active FREEDOM patch beats a placebo (sham) patch for pain and mobility in 118 adults over 14 days, using validated pain scales plus objective range-of-motion tests (Schober, goniometer, inclinometer).
Our honest read: This is the strongest evidence to date, and the design is the one that counts: randomized, double-blind and placebo-controlled — published in a real PubMed-indexed journal (Pain and Therapy, 2025). It reported a significant drop in pain severity (median about 2.75 points, p<0.001), measurable mobility gains, and no adverse events. The honest caveats: it was funded by the manufacturer, two authors were paid investigators, and it’s a single study with no independent replication yet. Real and meaningful — not the final word.
RESTORE-001 — ongoing trial (NCT06505005)
Ongoing · no results yetWhat it measured: Whether an active FREEDOM/REM patch beats a sham patch for pain and sleep in 150 adults, using validated tools (Brief Pain Inventory, Pittsburgh Sleep Quality Index) and wearable sleep trackers.
Our honest read: A second, larger gold-standard trial — separate from the published RESTORE Study above, and with the same rigorous randomized, double-blind, placebo-controlled design. It is still enrolling, with no results published yet. If it independently replicates the published trial, that would strengthen the case considerably. Watch this one.
HARMONI Study — Sleep & Quality of Life
Preliminary / limitedWhat it measured: Self-reported sleep quality and quality-of-life after using a haptic vibrotactile sleep patch; co-authored by a recognized sleep physician (Doghramji).
Our honest read: Reported improvements in sleep and daily life. Credible authorship is a plus, but the design lacks the randomization and blinding needed to separate real effect from expectation, and the venue has limited indexing. Encouraging, not conclusive.
HARMONI Study — Pain (Neuromatrix)
Preliminary / limitedWhat it measured: Pain severity and “interference” (how much pain disrupts daily life), framed around the brain’s pain-processing “neuromatrix.”
Our honest read: Suggests a reduction in pain interference, but the same limits apply: small, company-linked, and not a blinded randomized trial. Treat it as a hypothesis-builder, not proof the patch treats pain.
Anxiety Reduction with a Haptic Patch
Indexed journalWhat it measured: Change in anxiety symptoms among people using a haptic technology patch.
Our honest read: Notable mainly because it appeared in a PubMed-indexed journal (Journal of Family Medicine and Primary Care) — a more mainstream venue than most. Still early-stage and limited in size, but a cut above the others on where it was published.
VTT Patch in Dental Sedation (Pilot)
Preliminary / limitedWhat it measured: Whether a VTT patch could support relaxation/sedation in a real dental clinic setting (a small pilot).
Our honest read: A pilot is a first look, not a verdict — tiny sample, no control group. Interesting real-world signal; nowhere near proof.
So how strong is the evidence, really?
Put plainly: the research is early and mostly company-connected — but it now includes one genuinely strong study. Several of the earlier studies weren’t randomized or blinded, which means they can’t separate a real physical effect from the very powerful placebo effect, especially for subjective things like sleep, stress and pain. A few appeared in lesser-recognized journals; the anxiety study was PubMed-indexed; and — importantly — the 2025 RESTORE Study was a double-blind, placebo-controlled RCT in a PubMed-indexed journal.
For the first time, a study that can speak to cause and effect has been published: the randomized, double-blind, placebo-controlled RESTORE Study (2025) reported a significant reduction in pain versus placebo, with no adverse events. That’s a real milestone. It is still one company-funded trial without independent replication, and a second, larger trial (RESTORE-001) hasn’t reported yet — so the honest scientific status is now: plausible, promising, with early gold-standard support, but not yet independently proven or FDA-approved to treat any medical condition.
The broader vibrotactile science (and why it’s not the same thing)
Here’s where it gets genuinely interesting. Vibrotactile stimulation as a field is real and peer-reviewed: high-quality systematic reviews show that skin-level sensory stimulation can meaningfully help balance, gait and proprioception, especially in rehabilitation. That establishes the mechanism is biologically plausible — the skin really can send signals the nervous system acts on. The catch: this research almost always uses active, powered feedback devices in clinical settings, not a passive adhesive patch. So it supports the idea behind Super Patch without proving that this specific product delivers those benefits. Two representative peer-reviewed sources:
- Vibrotactile rehabilitation & balance in neurological disease (systematic review & meta-analysis)
- Proprioceptive recognition through vibrotactile stimulation (PubMed)
The independent, skeptical view
In fairness, credible pain specialists are unconvinced. An independent review from the Quebec Pain Research Network notes the patch looks like plain flexible plastic with no detectable vibration, that the cited studies lacked randomization and blinding, that it isn’t approved by Health Canada, and that the placebo effect could explain much of the positive feedback. We think that skepticism is reasonable, and you should weigh it. View source →
What this actually means for you
You don’t need a PhD to make a smart call here. Because there are no drugs, stimulants or chemicals and nothing is absorbed, the physical risk of trying a patch is low. That’s very different from whether it’s proven — it isn’t, not yet, for any medical condition.
A sensible way to think about it: if you have realistic expectations, treat it as a low-commitment experiment alongside good habits (sleep routine, movement, daylight), and give it a fair trial, you’ll quickly learn whether it does anything for you. There’s a 30-day money-back guarantee if it doesn’t — note that shipping isn’t refunded and conditions apply, so it’s a fair trial, not a no-strings one.
Want to try it the smart way?
Drug-free, backed by a 30-day money-back guarantee (shipping not refunded; conditions apply). Buy directly from the official store below.
Key takeaways
- Real studies exist on Super Patch — sleep, pain, anxiety, dental — some by credentialed clinicians.
- A published 2025 RCT (the RESTORE Study — randomized, double-blind, placebo-controlled, 118 people) reported significant pain relief — but it’s company-funded and not yet independently replicated.
- Most of the other studies are company-sponsored and weren’t randomized or blinded, so placebo can’t be ruled out; a second, larger trial (RESTORE-001) is still running.
- The broader vibrotactile science is legitimate, but studies active devices — not this passive patch.
- Honest status: plausible and low-risk to try, not medically proven. Not FDA-approved to treat any disease.
Frequently asked questions
Are there any real studies on Super Patch?
Yes. In 2025 a randomized, double-blind, placebo-controlled trial (the RESTORE Study) was published in the PubMed-indexed journal Pain and Therapy, reporting significant pain reduction. There are also earlier studies on sleep (the HARMONI study, co-authored by a recognized sleep physician), pain, anxiety (also PubMed-indexed) and a dental-sedation pilot. Most are company-sponsored and several of the earlier ones weren’t randomized or blinded, so the published RCT carries the most weight — but independent replication is still needed.
Is there a randomized, placebo-controlled trial?
Yes — and as of 2025 one has been published. The RESTORE Study (Pain and Therapy, 2025; PMID 41057672) was a randomized, double-blind, placebo-controlled trial of 118 adults that reported a significant reduction in pain versus a sham patch, with no adverse events. The main caveats: it was funded by the manufacturer and hasn’t been independently replicated yet. A second, larger trial (RESTORE-001 / NCT06505005) is still running.
Does the vibrotactile science prove the patch works?
Not for this product. Peer-reviewed research shows vibrotactile stimulation can help balance and proprioception, but that work uses active, powered devices in clinical settings, not a passive adhesive patch. It makes the idea plausible; it does not prove the Super Patch product treats any condition.
Is Super Patch FDA-approved?
No. Super Patch products are not FDA-approved to diagnose, treat, cure or prevent any disease. Some products may be FDA-registered, which is not the same as approval, and it is not approved by Health Canada.
Could the results just be placebo?
For the earlier, unblinded studies — possibly, in part; the placebo effect is strong and real for subjective outcomes like sleep, stress and pain. The 2025 RESTORE Study specifically addressed this with a double-blind, placebo-controlled design and still found a benefit over the sham patch, which is more convincing. The remaining caveat is that it’s company-funded and hasn’t been independently replicated yet.
Is it worth trying?
Because it’s drug-free and nothing is absorbed, the physical risk is low, and there’s a 30-day money-back guarantee (shipping not refunded; conditions apply). If you keep expectations realistic and pair it with good habits, it’s a low-commitment thing to test for yourself — just don’t treat it as a medical treatment.
That Recovery Room is an independent affiliate of The Super Patch Company and may earn a commission on purchases made through our links, at no extra cost to you. This page is for general information and honest review only; it is not medical advice, and Super Patch products are not intended to diagnose, treat, cure or prevent any disease. Always consult a qualified healthcare professional about your health.